|
MRPL42 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.420100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.382400E-03 |
| Normal-vs-Stage2 |
6.637000E-01 |
| Normal-vs-Stage3 |
3.605900E-04 |
| Normal-vs-Stage4 |
3.48630000002181E-06 |
| Stage1-vs-Stage2 |
5.002300E-02 |
| Stage1-vs-Stage3 |
8.595900E-02 |
| Stage1-vs-Stage4 |
1.191950E-02 |
| Stage2-vs-Stage3 |
5.398200E-03 |
| Stage2-vs-Stage4 |
4.798500E-04 |
| Stage3-vs-Stage4 |
2.923800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.276140E-03 |
| Normal-vs-AfricanAmerican |
2.751800E-01 |
| Normal-vs-Asian |
2.201200E-04 |
| Caucasian-vs-AfricanAmerican |
2.616600E-01 |
| Caucasian-vs-Asian |
2.636200E-01 |
| AfricanAmerican-vs-Asian |
7.566400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.168500E-04 |
| Normal-vs-Female |
1.019960E-02 |
| Male-vs-Female |
4.855600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.921400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.230100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.498300E-02 |
| Normal-vs-Age(81-100Yrs) |
2.403200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.985200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.316800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.532400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.502600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.449800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.635400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.581400E-01 |
| Classical-VS-Follicular |
5.904000E-03 |
| Classical-VS-Other |
6.165400E-01 |
| Classical-VS-Normal |
5.960100E-04 |
| Tall-VS-Follicular |
3.422200E-03 |
| Tall-VS-Other |
9.723000E-01 |
| Tall-VS-Normal |
9.248300E-04 |
| Follicular-VS-Other |
2.211600E-01 |
| Follicular-VS-Normal |
7.098400E-01 |
| Other-VS-Normal |
5.345600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.296300E-03 |
| Normal-vs-N1 |
1.67696999999745E-05 |
| N0-vs-N1 |
2.756000E-02 |
|
|
